Trenbolone Enanthate — Dosing, Cycles, Half-Life & Side Effects

Trenbolone Enanthate is a 19-nortestosterone derivative with a half-life of 7 days (168 hours). CRITICAL WARNINGS: (1) 19-nor compound with RISK OF PERMANENT SUPPRESSION. (2) SIGNIFICANT MENTAL HEALTH EFFECTS including insomnia, night sweats, anxiety, paranoia, aggression, and mood instability. (3) Cardiovascular stress is substantial. Long-acting ester variant with fewer injections but extended clearance. ADVANCED USERS ONLY. Primary risks include strong HPTA suppression, prolonged 19-nor metabolite clearance affecting PCT timing. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.

Quick Facts

Class19-nor
Half-life7 days (168 hours)
Detection window150 days
AromatizationNo
HepatotoxicityLow
Suppression10/10
17α-alkylatedNo
19-nor structureYes (extended metabolite clearance)
Administrationinjectable

Typical Dosing Ranges

Common dose range: 200-600mg/week

Cycle length: 10-16 weeks

Time to steady state: ~35 days

Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.

Stacking Considerations

PCT Requirements

  • This compound causes clinically meaningful HPTA suppression. Post-cycle therapy is recommended.
  • As a 19-nor, metabolites persist for weeks after last dose — PCT start should be delayed until apparent half-life clearance plus adequate wash-out (typically 4–6+ weeks post-last-injection for nandrolone; longer for trenbolone-dominant stacks).
  • Depot clearance estimate: ~35 days post-last-dose before SERM start (5 × apparent depot half-life of 168h).
  • Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
  • Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.

Side Effect Profile

  • SEVERE MENTAL HEALTH EFFECTS - insomnia, night sweats, anxiety, paranoia, irritability, aggression ('Tren rage')
  • RISK OF PERMANENT HPTA SUPPRESSION - 19-nor metabolites persist
  • Cardiovascular strain - significant impact on lipids and blood pressure
  • Prolactin elevation - may require cabergoline
  • Reduced cardio capacity ('Tren cough', respiratory effects)
  • Extended clearance time - longer PCT delay than Acetate
  • Liver stress at high doses despite not being 17α-alkylated
  • Not compatible with alcohol - severe reaction

Known Interactions

  • Trenbolone Acetate + Clenbuterol

    majorcardiovascular

    Both significantly impact cardiovascular system. Trenbolone raises BP, clenbuterol stresses heart.

    Recommendation: Avoid combination. If used, monitor BP and heart rate closely.

    Monitor: Blood pressure, Heart rate, ECG

  • Trenbolone Acetate + T3 (Cytomel/Liothyronine)

    moderatecardiovascular

    T3 increases metabolism and heart rate while trenbolone affects cardiovascular health.

    Recommendation: Use lowest effective doses. Monitor vitals closely.

    Monitor: Heart rate, Blood pressure, TSH

  • Both are 19-nor compounds affecting prolactin and progesterone. Compounding effects on HPTA.

    Recommendation: Consider prolactin management (cabergoline/P5P). Recovery may be prolonged.

    Monitor: Prolactin, Progesterone, LH, FSH

  • Deca and trenbolone are both 19-nors with long-lasting HPTA suppression.

    Recommendation: Not recommended together. Choose one 19-nor per cycle.

    Monitor: Prolactin, LH, FSH, Recovery timeline

  • Tamoxifen may up-regulate progestin receptors when used with 19-nor compounds.

    Recommendation: Consider enclomiphene as alternative SERM for PCT after trenbolone cycles.

    Monitor: Progesterone, Prolactin, LH, FSH

Monitoring (Bloodwork & Vitals)

  • Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
  • Lipid panel (total cholesterol, HDL, LDL, triglycerides)
  • CBC (hemoglobin, hematocrit — watch for erythrocytosis)
  • Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
  • Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)

Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.

Frequently Asked Questions

What is the half-life of Trenbolone Enanthate?

Trenbolone Enanthate has a half-life of approximately 7 days (168 hours). Clearance estimate: 168h × 5 = 840h = 35 days. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.

What is the typical dose range for Trenbolone Enanthate?

Commonly reported ranges for Trenbolone Enanthate: 200-600mg/week. Cycle length: 10-16 weeks. These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.

Does Trenbolone Enanthate suppress natural testosterone?

Trenbolone Enanthate causes severe suppression of the HPTA axis (score 10/10). Post-cycle therapy (PCT) is recommended after use. As a 19-nor compound, metabolites persist for weeks-to-months and shift PCT timing later than non-19-nor cycles.

Is Trenbolone Enanthate liver toxic?

Hepatotoxicity rating: Low. Non-17αα compound — liver stress is lower but still warrants periodic monitoring during a cycle.

Does Trenbolone Enanthate aromatize to estrogen?

Aromatization profile: No. Minimal to no aromatization expected, so aromatase inhibitors are not typically indicated for this compound alone.

What is Trenbolone Enanthate typically used for?

Trenbolone Enanthate is commonly used for: ADVANCED USERS ONLY - not for beginners under any circumstances, Competition prep (by experienced users), Those who have assessed and accepted mental health risks. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.

Citations

  1. Ester chemistry extrapolation. 2004. Clinical pharmacology reference — Half-life approximately 7-10 days estimated from enanthate ester analogy with testosterone enanthate. No human PK data.
  2. Liu et al.. 2025. Substance Use & Misuse — AAS meta-analysis: SBP +12.43 mmHg (95% CI: 9.59-15.26), LDL-C +9.12 mg/dL (95% CI: 6.75-11.49)
  3. Minto CF et al.. 1997. J Pharmacol Exp Ther — Trenbolone enanthate half-life extrapolated from ester-chain PK class (Minto 1997 testosterone esters) - approximately 5-7 days in humans. NO HUMAN TRENBOLONE-SPECIFIC PK DATA EXISTS
  4. Hartgens F, Kuipers H. 2004. Sports Medicine — 19-nor AAS suppression - trenbolone enanthate shares trenbolone acetate's HPTA suppression profile (same active compound, different ester); supports suppressionScore 10/10
  5. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004

Disclaimer

StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use Trenbolone Enanthate. Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.

Skip to main content